Eden Tesfu
Dr. Eden Tesfu currently works as a Director of Protein Sciences within Bayer’s Crop Sciences Division. In this capacity, she leads a diverse team of scientists responsible for gene sourcing, protein production, screening, characterization, mode of action and structure determination capabilities as well as overall innovation to enable the next generation of biotech traits. Her 18+ year multi-industry career extends across Chemistry, Biotechnology, and Regulatory strategies.
As strategic leader with experience driving projects in discovery science and product development, Dr. Tesfu partners effectively with colleagues across R&D, Product Supply and Commercial organizations to deliver profitable business solutions on a global scale. She has a passion for global food security and enjoys working on agricultural productivity innovations.
Prior to joining Bayer, Dr. Tesfu held progressively responsible positions in Chemistry at Pfizer and EAG labs. A recognized leader in her field, Dr. Tesfu values collaboration and partnerships to foster innovation. She serves on the Industry Advisory Board for the University of Missouri-St. Louis’s Department of Chemistry and Biochemistry and is an executive member of the American Chemical Society (ACS) Agro division.
Dr. Tesfu holds a B.Sc. in Chemistry from the University of Asmara-Eritrea and M.Sc. and Ph.D. degrees in Organic Chemistry from Washington University in St. Louis. When she is not working, she enjoys cooking and spending time with her family in various activities. Dr. Tesfu, her husband and their three kids live in Chesterfield, MO.
â€
Bayer Crop Science
Transforming Supply Chains with Engineered Proteins
-
This discussion brings together leaders from global consumer goods and materials companies to examine how engineered proteins can reshape supply chains, improve product performance, and reduce environmental impact. Speakers will share perspectives on building effective industry partnerships, balancing cost efficiency with quality, and navigating regulatory landscapes. The panel aims to understand better the collaborative pathways that turn cutting-edge protein design into widely adopted commercial solutions.